Needleless Jet Injected (J-Tip) Lidocaine in Children Undergoing Regional Anesthesia Prior to Knee Arthroscopy

Knee Injury Clinical Trial

Official title:

Randomized, Controlled Trial of Needleless Jet Injected (J-Tip) Lidocaine in Children Undergoing Regional Anesthesia Prior to Knee Arthroscopy.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02649322
• Other study ID #: 14.099.08
• Status: Completed
• Phase: N/A
• Start date: September 3, 2015
• Est. completion date: August 28, 2019

Study information

• Verified date: April 2020
• Source: Orlando Health, Inc.
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Purpose of this study is to investigate the pain outcomes and satisfaction of pain relief for pediatric patients receiving needleless jet-injected (J-Tip) lidocaine prior to regional anesthesia with femoral and/or sciatic nerve block and general anesthesia for arthroscopic knee surgery compared to femoral nerve block and/or sciatic nerve block with needle injected lidocaine prior to regional and general anesthesia.

Description:

The J-tip device has not been reported for use prior to regional block anesthesia prior to femoral or sciatic nerve blocks. The use of the J-tip device for lidocaine introduction prior to femoral or sciatic blocks at Arnold Palmer Medical Center has been up to the discretion of the anesthesiologist. It has been anecdotally reported at our institution to have equal or better pain relief for the regional nerve blocks as needle introduction of lidocaine.

This study seeks to evaluate the difference in pain from local anesthetic infiltration with J-tip needleless injection device compared to needle injection by use of Visual Analog Scales.

• To evaluate efficacy of femoral nerve block after J-tip device lidocaine injection post operatively by use of Visual Analog Scales.

• To assess patient and parent satisfaction with J-tip device use by satisfaction questionnaire.

• To assess changes in post operative pain medication amounts with J-tip device use.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 115
• Est. completion date: August 28, 2019
• Est. primary completion date: August 28, 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: 11 Years to 17 Years

Eligibility

Inclusion Criteria:

Subjects between the ages of eleven and seventeen undergoing arthroscopic knee surgery.

• Able to independently complete the Visual Analog pain scales.

• Subjects who are neurologically intact at area of injection.

• English speaking.

Exclusion Criteria:

• Subjects with known allergies to lidocaine.

• Presence of developmental delay.

• Subjects with blood disorders affecting coagulation.

• Subjects on blood thinners.

• Subjects receiving chemotherapeutic agents.

• Those who use or receive analgesia prior to procedure, except for acetaminophen or Non-steroidal anti-inflammatory medications.

• Any other local sedation at the area of nerve block injection.

• Non-English Speaking

• Subjects with signs of skin infection or pathology at the injection site.

Related Conditions & MeSH terms

• Knee Injuries
• Knee Injury

Intervention

Device:
• J-Tip
After sterile preparation, the J-tip injector will be placed on the skin at the selected site of the regional block needle introduction. Firm pressure will be placed with the J-tip injector on the site for the chosen block, the safety ring slid down, the trigger pressed and the tip held firmly on the skin for three seconds. One quarter of a milliliter of one percent lidocaine will be injected with the characteristic "pop" and "hissing" sounds inherent to the J-tip injector.
• Syringe and 25 gauge needle
The same initial timeout and sterile prep procedure will be followed for the use of local syringe and 25 gauge needle injection of 1% lidocaine ninety seconds prior to introduction of the regional block needle.

Locations

Country	Name	City	State
United States	Orlando Health	Orlando	Florida

Sponsors (1)

Lead Sponsor	Collaborator
Orlando Health, Inc.

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Baseline Pain Assessment Before Knee Arthroscopy Via the Visual Analog Scale.	Pain will be assessed via the Visual Analog Scale by the patient before administration of the nerve block. Patient will report on a scale of 0 to 10 what their perceived pain is. 0 is no pain with 10 being worst pain patient ever experienced.	During Baseline Assessment, Taking Approximately 20 Minutes, Before Nerve Block
Primary	Pain Assessment After Knee Arthroscopy Via the Visual Analog Scale	Pain will be assess via the Visual Analog Scale by the patient after the knee arthroscopy though first post op office visit and average of one week. Patient will report on a scale of 0 to 10 what their perceived pain is. 0 is no pain with 10 being worst pain patient ever experienced.	During Follow-up Assessment at an Average of 1 Week Post Op
Secondary	Satisfaction Via a 0 to 10 Rating Scale at Follow up	Patients will be asked to describe how satisfied they were with the knee arthroscopy via a 0 to 10 rating scale. Patient will report on a scale of 0 to 10 what their perceived satisfaction is. 0 is no satisfaction with 10 most satisfaction.	At the follow up appointment, an average of one week after the procedure.